Sight Sciences (SGHT)
(Delayed Data from NSDQ)
$6.70 USD
-0.20 (-2.90%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.83 +0.13 (1.94%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Sight Sciences, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 138 | 185 | 261 | 62 | -99,999 |
Receivables | 14 | 15 | 9 | 5 | NA |
Notes Receivable | 0 | 0 | 0 | 0 | NA |
Inventories | 8 | 6 | 3 | 3 | NA |
Other Current Assets | 3 | 3 | 4 | 1 | NA |
Total Current Assets | 163 | 210 | 277 | 71 | NA |
Net Property & Equipment | 2 | 2 | 1 | 1 | NA |
Investments & Advances | 0 | 0 | 0 | 0 | NA |
Other Non-Current Assets | 0 | 0 | 0 | 0 | NA |
Deferred Charges | 0 | 0 | 0 | 0 | NA |
Intangibles | 0 | 0 | 0 | 0 | NA |
Deposits & Other Assets | 1 | 0 | 0 | 0 | NA |
Total Assets | 167 | 213 | 280 | 73 | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | NA |
Accounts Payable | 2 | 3 | 3 | 2 | NA |
Current Portion Long-Term Debt | 2 | 0 | 0 | 0 | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | NA |
Accrued Expenses | 8 | 15 | 10 | 7 | NA |
Income Taxes Payable | 0 | 0 | 0 | 0 | NA |
Other Current Liabilities | 0 | 0 | 0 | 0 | NA |
Total Current Liabilities | 12 | 18 | 14 | 9 | NA |
Mortgages | 0 | 0 | 0 | 0 | NA |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | NA |
Convertible Debt | 0 | 0 | 0 | 0 | NA |
Long-Term Debt | 32 | 33 | 33 | 32 | NA |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | NA |
Other Non-Current Liabilities | 2 | 2 | 2 | 120 | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | NA |
Total Liabilities | 46 | 53 | 48 | 162 | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | NA |
Common Stock (Par) | 0 | 0 | 0 | 0 | NA |
Capital Surplus | 415 | 399 | 385 | 1 | NA |
Retained Earnings | -295 | -239 | -153 | -90 | NA |
Other Equity | 0 | 0 | 0 | 0 | NA |
Treasury Stock | 0 | 0 | 0 | 0 | NA |
Total Shareholder's Equity | 120 | 160 | 232 | -89 | NA |
Total Liabilities & Shareholder's Equity | 167 | 213 | 280 | 73 | NA |
Total Common Equity | 120 | 160 | 232 | -89 | 0 |
Shares Outstanding | 48.70 | 48.10 | 47.30 | NA | NA |
Book Value Per Share | 2.47 | 3.33 | 4.91 | 0.00 | 0.00 |
Fiscal Year End for Sight Sciences, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 118 | 127 | 138 | 145 | 155 |
Receivables | 20 | 16 | 14 | 17 | 18 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 7 | 7 | 8 | 9 | 8 |
Other Current Assets | 1 | 2 | 3 | 3 | 2 |
Total Current Assets | 146 | 152 | 163 | 174 | 182 |
Net Property & Equipment | 1 | 2 | 2 | 2 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 0 |
Total Assets | 150 | 156 | 167 | 177 | 185 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 2 | 4 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 2 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 11 | 10 | 8 | 11 | 11 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 13 | 12 | 12 | 14 | 14 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 34 | 34 | 32 | 34 | 34 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 2 | 1 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 48 | 46 | 46 | 50 | 49 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 425 | 420 | 415 | 411 | 407 |
Retained Earnings | -323 | -311 | -295 | -284 | -271 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 102 | 109 | 120 | 127 | 136 |
Total Liabilities & Shareholder's Equity | 150 | 156 | 167 | 177 | 185 |
Total Common Equity | 102 | 109 | 120 | 127 | 136 |
Shares Outstanding | 50.30 | 49.50 | 48.70 | 48.60 | 48.40 |
Book Value Per Share | 2.02 | 2.21 | 2.47 | 2.61 | 2.81 |